We are live on ! Find out more
Qube Research & Technologies (QRT)

Qube Research & Technologies (QRT) Portfolio holdings

AUM $89.9B
1-Year Est. Return 20.22%
This Fund
S&P 500
This Quarter Est. Return
-4.58%
1 Year Est. Return
+20.22%
3 Year Est. Return
+42.42%
5 Year Est. Return
+23.97%
10 Year Est. Return
AUM
$38.3B
AUM Growth
+$10.8B
Cap. Flow
+$12.9B
Cap. Flow %
33.6%
Top 10 Hldgs %
9.4%
Holding
4,435
New
2,018
Increased
1,007
Reduced
916
Closed
371

Top Buys

Rank Stock Value
1
JNJ icon
Johnson & Johnson
JNJ
+$302M
2
ADBE icon
Adobe
ADBE
+$291M
3
AMZN icon
Amazon
AMZN
+$266M
4
MSFT icon
Microsoft
MSFT
+$257M
5
LLY icon
Eli Lilly
LLY
+$214M

Sector Composition

Rank Sector Weight
1 Technology 19.59%
2 Consumer Discretionary 12.46%
3 Financials 10.63%
4 Industrials 10.62%
5 Healthcare 10.25%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IMUX icon
3776
Immunic
IMUX
$188M
$85 ﹤0.01%
+6
New +$115
IMNM icon
3777
Immunome
IMNM
$2.56B
$84 ﹤0.01%
+10
New +$73
BYSI icon
3778
BeyondSpring
BYSI
$48.1M
$83 ﹤0.01%
+104
New +$102
CPSH icon
3779
CPS Technologies
CPSH
$76.7M
$83 ﹤0.01%
+30
New +$84
FLXS icon
3780
Flexsteel Industries
FLXS
$309M
$83 ﹤0.01%
+4
New +$82
AMZE
3781
Amaze Holdings
AMZE
$2.25M
$83 ﹤0.01%
+1
New +$82
ACER
3782
DELISTED
Acer Therapeutics Inc
ACER
$83 ﹤0.01%
+100
New +$82
SPI
3783
DELISTED
SPI Energy Co., Ltd. Ordinary Shares
SPI
$80 ﹤0.01%
+100
New +$114
LYT
3784
DELISTED
Lytus Technologies Holdings PTV. Ltd. Common Shares
LYT
$78 ﹤0.01%
+7
New +$158
ARQ icon
3785
Arq
ARQ
$85.4M
$77 ﹤0.01%
+43
New +$84
LITB
3786
LightInTheBox
LITB
$56M
$76 ﹤0.01%
+11
New +$86
VIOT
3787
Viomi Technology
VIOT
$50.8M
$76 ﹤0.01%
+75
New +$69
CRDF icon
3788
Cardiff Oncology
CRDF
$65M
$72 ﹤0.01%
+52
New +$88
CYD icon
3789
China Yuchai International
CYD
$1.75B
$71 ﹤0.01%
+7
New +$76
AURE
3790
Aurelion Inc
AURE
$62.9M
$71 ﹤0.01%
+2
New +$188
DMK
3791
DELISTED
DMK Pharmaceuticals Corporation Common Stock
DMK
$69 ﹤0.01%
+100
New +$128
ADAG
3792
Adagene
ADAG
$233M
$68 ﹤0.01%
+47
New +$64
MNOV icon
3793
MediciNova
MNOV
$65M
$67 ﹤0.01%
+32
New +$74
ACHL
3794
DELISTED
Achilles Therapeutics
ACHL
$66 ﹤0.01%
+73
New +$69
SMSI icon
3795
Smith Micro Software
SMSI
$14.1M
$65 ﹤0.01%
+1
New +$52
BLRX
3796
BioLineRX
BLRX
$12.3M
$64 ﹤0.01%
+1
New +$67
MOLN
3797
Molecular Partners
MOLN
$146M
$64 ﹤0.01%
+16
New +$91
CLLS
3798
Cellectis
CLLS
$291M
$63 ﹤0.01%
+40
New +$78
NXTC icon
3799
NextCure
NXTC
$20.8M
$62 ﹤0.01%
+4
New +$76
WRAP icon
3800
Wrap Technologies
WRAP
$99.8M
$62 ﹤0.01%
+41
New +$69

Similar funds

Qube Research & Technologies (QRT)'s Q3 2023 Portfolio in Review

As of Q3 2023, Qube Research & Technologies (QRT) held 4,435 positions worth $38.3B, up 39% from $27.5B the previous quarter. Its ten largest holdings account for 9.4% of the portfolio.

Qube Research & Technologies (QRT) deployed $12.9B of net new capital in Q3 2023, opening 2,018 new positions and adding to 1,007 existing holdings. Its largest new stake was Eli Lilly: 415,473 shares worth $223M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 21% a quarter earlier, followed by Consumer Discretionary and Financials.

On the sell side, the largest reduction was Alphabet (Google) Class C, an estimated $192M trimmed.

  • Qube Research & Technologies (QRT)'s largest Q3 2023 buy was Eli Lilly: 415,473 shares worth $223M.
  • Qube Research & Technologies (QRT) added most to Johnson & Johnson in Q3 2023, an estimated $302M increase.
  • Qube Research & Technologies (QRT)'s biggest Q3 2023 reduction was Alphabet (Google) Class C, cutting an estimated $192M.
  • Qube Research & Technologies (QRT) fully exited Walt Disney in Q3 2023, selling an estimated $134M.
  • Qube Research & Technologies (QRT)'s ten largest holdings make up 9.4% of its $38.3B portfolio in Q3 2023.
  • Qube Research & Technologies (QRT) opened 2,018 new positions and closed 371 in Q3 2023.
  • Qube Research & Technologies (QRT)'s portfolio value rose 39% quarter-over-quarter to $38.3B.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q3 2023, filed 13 Nov 2023.